Clinical Trial Update: Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial results summarize the efficacy, safety, tolerability, pharmacodynamics and pharmacokinetics of oral AIM-102 in adults with mild to moderate allerg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AIM-102

Snippet

Sponsor: AIM Therapeutics Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED